therapeutic 1,360 words KG: ent-gene-efa85237
Contents

NfL Reduction Therapy: Neuroprotective Strategies for Neurodegenerative Diseases

🔬 Protein Info
Gene Symbolent-gene-efa85237
KG Connections7 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (42)

Restoring Neuroprotective Tryptophan Metabolism via Targeted
Score: 0.61
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38
TREM2-mediated microglial tau clearance enhancement
Score: 0.62
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.82
Vagal Afferent Microbial Signal Modulation
Score: 0.62
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
Vocal Cord Neuroplasticity Stimulation
Score: 0.52
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.90
Circadian Clock-Autophagy Synchronization
Score: 0.76
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.75
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.75
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74
APOE-TREM2 Interaction Modulation
Score: 0.74
PARP1 Inhibition Therapy
Score: 0.74
CYP46A1 Overexpression Gene Therapy
Score: 0.73
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.71
Orexin-Microglia Modulation Therapy
Score: 0.71
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71
pg 1/3Next →

Related Analyses (30)

Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · completed
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived

Related Experiments (9)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.45
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.45

See Also (1)

Lipid Metabolism Dysregulation in Neurodegeneration
mechanism · Pages share 3 hypotheses

Knowledge Graph (7 edges)

h-2901c57778 targets ent-gene-efa85237
ent-gene-efa85237 targeted_by h-2901c57778
ent-gene-efa85237 data_in benchmark_ot_ad_answer_key:NFL
benchmark_ot_ad_answer_key:NFL data_in ent-gene-efa85237
h-var-c261b9d0cd targets ent-gene-efa85237
ent-gene-efa85237 targeted_by h-var-c261b9d0cd
39720677 identified patients for ent-gene-efa85237

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.